# Trachoma Elimination Study by Focused Antibiotic (TESFA)

> **NCT03523156** · PHASE4 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Trachoma

## Interventions

- **DRUG:** Azithromycin mass treatment
- **DRUG:** Azithromycin targeted treatment

## Key facts

- **NCT ID:** NCT03523156
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06
- **Primary completion:** 2026-04
- **Final completion:** 2027-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The Trachoma Elimination Study by Focused Antibiotic (TESFA): The Impact of an Enhanced Antibiotic Treatment Regimen on Trachoma in Amhara, Ethiopia is withdrawn due to severe delays and continued insecurity in the Amhara region of Ethiopia.
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523156, "Trachoma Elimination Study by Focused Antibiotic (TESFA)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03523156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*